Kasper Lykke Hansen

Kasper Lykke Hansen

Academic employee FU


  1. 2018
  2. Published

    Early human dispersals within the Americas

    Moreno-Mayar, J. V., Vinner, L., de Barros Damgaard, P., de la Fuente, C., Allentoft, M. E., Vimala, T., Racimo, F., Rasmussen, S., Margaryan, A., Iraeta Orbegozo, M., Mylopotamitaki, D., Alexandersen, V., Primeau, C., Gregersen, K., Hansen, K. L., Lynnerup, N., Kjær, K., Schroeder, H., Malaspinas, A. S., Sikora, M. & 2 others, Nielsen, Rasmus & Willerslev, Eske, 7 Dec 2018, In: Science (New York, N.Y.). 362, 6419, p. 1, 1-11 12 p., eaav2621.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Corrigendum to “Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's antiseizure efficacy” [Neuropharmacology 143 (2018) 186–204](S0028390818306774)(10.1016/j.neuropharm.2018.09.025)

    Brandt, C., Seja, P., Töllner, K., Römermann, K., Hampel, P., Kalesse, M., Kipper, A., Feit, P. W., Hansen, Kasper Lykke, Toft-Bertelsen, Trine Lisberg, Paavilainen, P., Spoljaric, I., Puskarjov, M., MacAulay, Nanna, Kaila, K. & Löscher, W., Dec 2018, In: Neuropharmacology. 143, p. 349-350 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

ID: 14344933